-- Valeant, Pershing eye shakeup to Allergan board
-- 
-- Thu May 08, 2014 09:01AM EDT
-- None



May 8 (Reuters) - Deal-making drugmaker Valeant Pharmaceuticals International Inc <VRX.TO> <VRX.N> said on Thursday that it plans with activist investor Pershing Square to pursue a special meeting to change up the board of Allergan Inc <AGN.N>, which it hopes to acquire.

